Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1975;46:591-595
© 1975 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ANDERSON, G. G.
Right arrow Articles by STEEGE, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ANDERSON, G. G.
Right arrow Articles by STEEGE, J. F.

Clinical Experience Using Intraamniotic Prostaglandin F2{alpha} for Midtrimester Abortion in 600 Patients

GERALD G. ANDERSON, MD, FACOG and JOHN F. STEEGE, MD

From the Department of Obstetrics and Gynecology, Yule University School of Medicine, New Haven, Connecticut

Abstract

Six hundred consecutive patients received intraamniotie prostaglandin F2{alpha}, to induce midtrimester abortion. The PGF2{alpha} was administered by a general population of gynecologists according to a standard protocol. The aim of the study was to observe whether results would be similar to those reported in various research studies. Of 600 abortions, 460 were complete, 140 were incomplete, and there were no abortion failures. Other parameters were also similar to previous research results, indicating that PGF2{alpha} can be an effective and safe means of inducing midtrimester abortion when administered by the practicing gynecologist.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the American College of Obstetricians and Gynecologists.